Clarus Therapeutics (BLUW) EBITDA (2025 - 2026)
Clarus Therapeutics (BLUW) EBITDA from Mar 31, 2025 to Mar 31, 2026. The TTM Clarus Therapeutics (BLUW) EBITDA is -$1.38M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Clarus Therapeutics (BLUW) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +1625.00% |
Annual EBITDA change of Clarus Therapeutics (BLUW)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$330K | -70.80% |
| 2025 | -$1.13M | N/A |
| 2024 | $0 | N/A |